Strong Q1 2026 performance with 9% premium growth, 8th consecutive quarter of growth, improved expense ratio (29.7% vs 29.9% YoY), solid 93.2% combined ratio indicating underwriting profitability, and 92.4% policy retention rate. Management expressed confidence in sustainable mid-single-digit growth strategy. However, slight offset by declining net income per share ($0.43 vs $0.47 YoY) and current accident-year loss ratio pressure from medical inflation and competitive pricing environment.
Also mentions AMSF
Articles that tag AMSF but are mainly about other companies.
Profits have declined for two consecutive years with anemic job growth outlook. 2025 special dividend was smallest in a decade at 8.4% true yield, signaling reduced capacity for future specials.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
